ARS Pharmaceuticals Inc. (SPRY)

SPRY trades at $10.31, 3.1% above the near-term max pain of $10 expiring Oct 17, 2025 (11 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($7.5-$15), signaling increased put positioning or downside protection. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for SPRY shows a downward trend from 15 to 7.5, indicating bearish sentiment or hedging activity. The 68% spread signals divergent expectations across timeframes. Levels distributed around 10.31. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.